Replies to post #258818 on NeoMedia Technologies, Inc (NEOM)

[SparklingAnjewel]

very interesting.....

[Hoofman]

COOL POST! Thanks for taking the time and breaking it down like you did. So the real question is are you back in long term ;-)

[whizknock]

Disturbing but well written post.

Did you come across any public companies that the doc helped the shareholders?

[Harold Fieldt]

now that is one awesome analysis. just lost my virginity. there seems to be a COMPLETELY different world out there in the doc's stratosphere. must learn to think bigger than bigger. thanks.

[looznbux]

CONGRATS! to you on compiling the best post I've read on this board.

Patrick doesn't give a $hit about $NEOM; in fact he doesn't really care about the patents (my humble opinion, of course). Check the dates on the patents; most of the relevant ones to the current $NEOM pump were issued in 2008.

NOTE: Millions of $$$ to Patrick is peanuts that is a pittance of a tax write-off for a person with revenues/profits/assets in the BILLIONS.

I worked as an indirect collaborator with Patrick in the early 1990s on an artificial pancreas project in collaboration with Specialty Labs, Inc. (now Quest Diagnostics, Inc. [NASDAQ: DGX]). When he wants something because he sees intrinsic and/or altruistic value in it, he BUYS it. If it's unavailable for immediate purchase, he will in-license the technology until he can leverage the acquisition of that which he seeks, which in this case is a possible interest in the technology.

I also worked with Abraxis in the development stages of Abraxane. Most reading this board are aware that Abraxis was sold to Celgene for ~$2.9 Billion. Patrick's a very astute businessman, but I'm going out on a very solid limb and publicly stating that $NEOM is NOT the primary interest here. If anything, it is the Intellectual Property and its applications.

'Nuff said. Trade this POS; do not fall in love with it; don't think it's an "investment" of a lifetime; don't heed the words of the pumper boys & gals. Just TRADE the POS, making sure you set loss limits if you're "long" and stick by them.

I made a bit of nice change here and will never make a disparaging remark about Patrick. His kids go to school with my friends' kids and from the few times I dealt with him in the 90's he's a nice guy. Just take everything you read for what it's worth when it comes to OTC & stinky pinky stocks...99% of them are garbage irrespective of who's involved.

GLTYA!

[Butterfingers]

Thank you, that's one outstanding post!!

[canuck44]

Thank you.
Must read again and again.A bit of language barrier + lack of market knowledge.
To me it is very scary. Earlier I had a post deleted. I think It was because I said the good doctor would not like to loose face, well I think we or more I might loose face.


Hoping for the best
Canuck44

[yellowjacket]

Now that's real DD folks! Thanks, B4B. :-) Betchya that causes a bit of pucker factor for many newbies here. The Doc could just be another finance whore ala YA...only with a different MO. Perhaps there is/will be some professional courtesy extended/enjoyed between them that we're not/never will be privy to prior to Default/BK?

[Erz]

Thank you,i will follow you!

[7kidsmom]

WOW... What deep DD! You really have us thinking here in Newbieland!

[Poptech]

buck:

Interesting read. I was familiar with one of the companies and when put two others a pattern does emerge.

You had two contrasting points. 1) Dr. Soon-Shiong own 29% of NeoMedia and 2) There was 1 billion in float.

He bought 113.5M shares so on your float numbers, he owns around 10%. Throw in the as converted shares owned by YA, and he was about 3%. Not much of dent to start a buyout.

[FORTY-8]

To Bucks: simply a tour-de-force. Right up there with that of kayes. Magnificent! I tip my hat to you!

[FinanciallyFree]

Hell of a post! Great analysis, much better than the normal- TOO THE MOON, or a GONNA DROP type posts we get on here.

Thanks for the insight.

[cjzak]

Nice work. We shall 'soon' see if Dr. Soon follows this pattern with NEOM. Guess your saying he's not the 'White Knight' all of us shareholders were hoping he'd be, right?

[NR]

B4B - Good job. Now that I know some of the past with companies he's involved in. Sheds a whole new light on things, for me. Thanks for sharing your research. Kudos

[TheFinalCD]

Excellent ~DD~ but double check your dates and 29%

Now, Dr. Patrick Soon-Shiong/Global Grid LLC purchased 29% of common shares of NeoMedia on open market March 16-18, 2012

http://ih.advfn.com/p.php?pid=nmona&article=51710654





PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

25.9%



ITEM 3.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.


Between March 14, 2012 and March 16, 2012, Global Grid purchased an aggregate of 113,494,743 shares of Common Stock on the open market at an aggregate purchase price (excluding trading commissions and related administrative costs) of $3,658,274.15, as follows:




On March 14, 2012, Global Grid acquired an aggregate of 11,894,651 shares of Common Stock at a weighted average price of $0.01 per share, at prices ranging from $0.009 to $0.013 per share.



On March 15, 2012, Global Grid acquired an aggregate of 25,000,000 shares of Common Stock at a weighted average price of $0.02 per share, at prices ranging from $0.01 to $0.02 per share.



On March 16, 2012, Global Grid acquired an aggregate of 76,600,092 shares of Common Stock at a weighted average price of $0.04 per share, at prices ranging from $0.02 to $0.06 per share.


The funds used by Global Grid to purchase these shares of Common Stock were from internal sources.

The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission full information regarding the number of shares purchased in the transactions described above at each separate price.

[QQQ_U]

Bucks4Buckeyes:
Thank you very much for your great DD!
____________________________________________________

A Dose of Reality For NEOM Shareholders:

Not all links are provided, but I have them available in my research.

GENERAL FACTS:
1. Dr. Soon-Shiong has previously announced he is assembling an advanced-care health network.
2. The main “parent” companies Dr. Soon-Shiong are assembling for this system are: NantWorks, NantHealth, NantMobile, NantHoldings & NantInternational.
3. Among Dr. Soon-Shiong’s companies which get involved in the public companies are: Global Grid, California Capital Equity,
4. Just a few of the companies which he has acquired/controls in this health network:
Institute for Advanced Health
Lambda Rail
LookTel
Ziosoft
Vodafone
Dossia
Toumaz
Vitality
Boston Life Labs
Strand Diagnostics
Net.Orange
Equipois
NanoH2O
Ingenious Innovations Group

Especially (for our purposes) publicly-traded companies:
Conjuchem
APP
KeyOn


5. Now, Dr. Patrick Soon-Shiong/Global Grid LLC purchased 29% of common shares of NeoMedia on open market March 16-18, 2012.

Interesting link for recent events with Dr. Soon-Shiong:
http://us.generation-nt.com/s/patrick+soon+shiong/


REASONABLE ASSUMPTIONS:
1. Since Dr. Soon-Shiong has patented his health “system,” AND since he is investing a few billion dollars in it – I think it only reasonable that he would want complete control over his entire health system – hence the “need” even for Lamda Rail, he is building his own, personal internet. He will not rely on Google, Bing, etc. to allow them to mess with his machine.
2. Each company which he deems integral to his health system are simply components to the overall machine. Thus, he needs complete control over these companies – without it, his entire “machine” will break down. The whole is much more important than the individual parts.
3. The more progress he makes with his “machine,” the more likely the new “parts” will cost.
4. Some companies will cooperate and work together (like Cysco with Lamda Rail and the multiple independent companies in Dossia – I haven’t bothered to examine Ericsson’s ties with Soon-Shiong yet).
5. Once the “machine” is completely assembled and operating well, he can charge what he wishes for other companies/professionals/health insurance companies to cooperate, since it will most likely be the “crown jewels” of all health care systems.

PRIVATE COMPANIES:
The man is a genius, let’s face it. He can also recognize talent and he is rapidly capitalizing many private companies who have a unique niche in the market or have the potential to bring a unique specialty to his health care system. He is funding them and giving them governance and letting them grow, and many are becoming profitable.

He is the private company’s generous benefactor!

PUBLIC COMPANIES:
However, I find a common thread, so far, in the public companies which Dr. Soon-Shiong acquires/controls.

CONJUCHEM
Conjuchem was a publicly-traded company in Canada. It went bankrupt and now it is a private company relocated in LA – privately-owned by Soon-Shiong.

Announces bankruptcy 7/21/2010
http://www.bloomberg.com/apps/news?pid=conewsstory&tkr=CJB:CN&sid=aqC8yRv3QZ1k

Officially Restructured 8/30/2011
http://article.wn.com/view/2011/08/30/ConjuChem_Resumes_Operations_Led_by_Dr_Patrick_SoonShiong/


APP PHARMACEUTICALS
APP underwent a successful IPO in 2001. It became Abraxis and then they spun off the APP Pharmaceuticals in 2007.
http://pro.edgar-online.com/ipo.aspx?ColLeft=3c2bcac1-dbf5-4776-9d3b-89001baee8d5&ColRight=76baaeb6-2549-44f5-8e1d-cd700701e704&cikid=91266&tabIndex=2&coname=APP+PHARMACEUTICALS%2C+INC.&fnid=15098&ipo=1&ColLeft=3c2bcac1-dbf5-4776-9d3b-89001baee8d5&ColRight=76baaeb6-2549-44f5-8e1d-cd700701e704&cikid=91266&tabIndex=2&coname=APP%20PHARMACEUTICALS,%20INC.&fnid=15098&ipo=1

APP Pharmaceuticals is a big deal, they are the primary producer of heparin (for diabetes) in the US. Within a year they went through a reverse merger with Fresenius Kabi Pharmaceutical Holding, Inc. (Just so happens that Soon-Shiong is on the BOD).
http://people.forbes.com/profile/patrick-soon-shiong/623

The shareholders who owned APP stock in 2008 – 3 YEARS LATER – were finally looking forward to receiving a good payout.
http://www.stockmarketsreview.com/news/104844/

Quote:Analysts Expect $6 a Share Payout for APCVZ Owners Following Q4 Results
February 15, 2011, Tuesday, 14:03 GMT
Analysts are expecting a payout of $6 a share from Fresenius Kabi Pharmaceuticals Holdings inc. (NASDAQ: APCVZ) to its owners following the release of its annual report later this month.

This would be an additional cash payment from a merger that took place on September 10, 2008 when Fresenius Kabi Pharmaceuticals Holdings completed the acquisition of APP Pharmaceuticals, Inc. The holders of APCVZ are entitled to an additional payment which analysts project will be $6 a share.

The company is expected to announce this payout shortly after releasing its fourth quarter results.

The closing price for Fresenius Kabi Pharmaceuticals Holdings (APCVZ) last Friday was around $0.05 per share.


Oh, what a shame! In February 2011 it was realized that APP financials didn’t make enough money to pay out their old shareholders – even though their EBITDA was over $1.1 BILLION!
http://www.businesswire.com/news/home/20110222007664/en

Quote:Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 10-K
for APP Pharmaceuticals, Inc. (APP)
Contingent Value Rights Issued in September 2008 Will Expire Without Value
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) today filed its Form 10-K for APP which provides an update on the Contingent Value Rights (CVRs) granted to APP stockholders in September 2008 in conjunction with Fresenius Kabi Pharmaceuticals Holding’s acquisition of APP.
“Management’s Discussion and Analysis of Financial Condition and Results of Operations”
Pursuant to the agreement governing the CVRs, the right to receive a payment with respect to the CVRs was contingent upon APP achieving consolidated cumulative Adjusted EBITDA in excess of $1.268 billion for the measurement period (three years ending December 31, 2010). The consolidated Adjusted EBITDA for the measurement period was $1.126 billion. Since the cumulative Adjusted EBITDA did not exceed the required threshold, CVR holders will not receive any payments on the CVRs and the CVRs will expire without value.
The company will give formal notice to the NASDAQ Capital Market of its intention to deregister under the Securities Exchange Act of 1934 (the “Exchange Act”) and delist the CVRs from the NASDAQ. The Company will also terminate its obligation to file periodic reports, such as a Form 10-K, Form 10-Q or Form 8-K, under the Exchange Act. It is expected that the CVRs will cease trading on NASDAQ on March 4, 2011. The delisting is expected to be made effective by the NASDAQ prior to the end of the first quarter 2011.
About APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. is a fully-integrated pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. The company offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. Fresenius Kabi Pharmaceuticals Holding, Inc., a wholly owned subsidiary of Fresenius Kabi AG, acquired APP Pharmaceuticals, Inc. on September 10, 2008. For more information about APP Pharmaceuticals, Inc., please visit the company’s Web site at www.APPpharma.com.


Less than a month later, Fresenius Kabi Pharmaceutical Holding, Inc. officially delisted any more public connections to APP Pharmaceuticals.
http://www.biospace.com/News/fresenius-kabi-pharmaceuticals-holding-inc-files/213089

Quote:Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 25 to Delist and Deregister Contingent Value Rights for APP Pharmaceuticals
3/7/2011 5:27:21 PM
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that on March 4, 2011, it filed a Form 25 with the NASDAQ and the United States Securities and Exchange Commission with respect to its Contingent Value Rights (“CVRs”) listed on the NASDAQ Capital Market. As previously disclosed in its 10-K filing on February 23, 2011, the Form 25 will delist the CVRs from the NASDAQ and deregister the CVRs under Section 12(b) of the Securities and Exchange Act of 1934 (the “Exchange Act”). The NASDAQ suspended trading of the CVRs effective the close of trading on March 4, 2011. On or about March 15, 2011, the Company intends to suspend its reporting requirements under the Exchange Act pending deregistration of the CVRs


Personally, I think APCVZ is not long for the public market, their shares are only $.02. Private company, here we come!


KEYON
KeyOn (KEYO) is an interesting story, but is following an all-to-familiar story line, too.

They owed $4.5 to Sun West Bank, and extended the loan six years from June 2009 to June 2015.
http://www.sec.gov/Archives/edgar/data/1335294/000117120009000374/i00179_keyon-8k.htm

Then Cal Cap gave them the money to pay the note 12/3/10.
http://www.sec.gov/Archives/edgar/data/1335294/000117120010001101/0001171200-10-001101-index.htm

After restructuring their loan, they replaced their preferred stock with a more attractive preferred stock on 1/31/10
http://www.sec.gov/Archives/edgar/data/1335294/000117120010000106/0001171200-10-000106-index.htm

The next announcement was a vote put to their shareholders that California Capital Equity would give them a note for $15m if they would issue some preferred stock.
http://www.sec.gov/Archives/edgar/data/1335294/000117120010000108/i00040_keyon-8k.htm

By the time the next shareholder meeting rolled around, Cal Cap was already a 46% shareholder
http://www.sec.gov/Archives/edgar/data/1335294/000117120011000104/i00047_keyon-def14a.htm

Their shareholder meeting allowed them to convert a secured note from California Capital Partnership LP (owned by Patrick Soon Shiong) announced 2/4/11 to be held on 3/11/11
http://www.sec.gov/Archives/edgar/data/1335294/000114420411036857/0001144204-11-036857-index.htm

If you wonder how things are going for KeyOn, check out their filings, they have been buying many, many companies in outlying areas. Why? Soon-Shiong MUST have access to all hospitals and regions for his health network!

So…they must be doing great, right?

[edc]

Bucks, Thats one of the most interesting and insigthful posts that I remember. I'm losing it. That post was via Pop's link in his post.

[hinchback]

READ THIS NEOMers!! the best DD ever!